Influence of dose intensity in consolidation with HIDAC and other clinical and biological parameters in the survival of AML
| dc.coverage.spatial | América Latina | spa |
| dc.date.accessioned | 2020-11-17T20:19:41Z | |
| dc.date.accessioned | 2023-05-10T17:11:35Z | |
| dc.date.available | 2020-11-17T20:19:41Z | |
| dc.date.available | 2023-05-10T17:11:35Z | |
| dc.date.created | 2020 | |
| dc.identifier | https://www.hindawi.com/journals/jce/2020/8021095/ | spa |
| dc.identifier.issn | 1687-8566 / 1687-8558 (Electrónico) | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12032/90989 | |
| dc.format | spa | |
| dc.format.mimetype | application/pdf | spa |
| dc.language.iso | eng | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.title | Influence of dose intensity in consolidation with HIDAC and other clinical and biological parameters in the survival of AML | spa |
Arquivos deste item
| Arquivos | Tamanho | Formato | Visualização |
|---|---|---|---|
| 8021095.pdf | 579.8Kb | application/pdf | Visualizar/ |
Este item aparece na(s) seguinte(s) coleção(s)
Exceto quando indicado o contrário, a licença deste item é descrito como http://creativecommons.org/licenses/by-nc/4.0/